Format

Send to

Choose Destination
See comment in PubMed Commons below
Eur Respir J. 2014 Aug;44(2):361-70. doi: 10.1183/09031936.00209513. Epub 2014 Mar 13.

Glucocorticoids induce the production of the chemoattractant CCL20 in airway epithelium.

Author information

1
University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, Groningen University of Groningen, University Medical Center Groningen, GRIAC research Institute, Groningen University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen.
2
University of Groningen, University Medical Center Groningen, GRIAC research Institute, Groningen University of Groningen, University Medical Center Groningen, Dept of Pathology, Laboratory of Immunopathology, Groningen, The Netherlands.
3
University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, Groningen University of Groningen, University Medical Center Groningen, GRIAC research Institute, Groningen.
4
University of Groningen, University Medical Center Groningen, GRIAC research Institute, Groningen University of Groningen, University Medical Center Groningen, Dept of Pulmonology, Groningen.
5
University of Groningen, University Medical Center Groningen, Dept of Pathology and Medical Biology, Experimental Pulmonology and Inflammation Research, Groningen University of Groningen, University Medical Center Groningen, GRIAC research Institute, Groningen h.i.heijink@umcg.nl.

Abstract

Th17-mediated neutrophilic airway inflammation has been implicated in decreased response to glucocorticoids in asthma. We aimed to investigate the effect of glucocorticoids on the airway epithelial release of the neutrophilic and Th17-cell chemoattractant CCL20. We studied CCL20 and CXCL8 sputum levels in asthmatic subjects using inhaled glucocorticoids or not, and the effect of budesonide on CCL20 and CXCL8 production in primary bronchial epithelial cells. The mechanism behind the effect of budesonide-induced CCL20 production was studied in 16HBE14o- cells using inhibitors for the glucocorticoid receptor, intracellular pathways and metalloproteases. We observed higher levels of CCL20, but not CXCL8, in the sputum of asthmatics who used inhaled glucocorticoids. CCL20 levels correlated with inhaled glucocorticoid dose and sputum neutrophils. Budesonide increased tumour necrosis factor (TNF)-α-induced CCL20 by primary bronchial epithelium, while CXCL8 was suppressed. In 16HBE14o- cells, similar effects were observed at the CCL20 protein and mRNA levels, indicating transcriptional regulation. Although TNF-α-induced CCL20 release was dependent on the ERK, p38 and STAT3 pathways, the increase by budesonide was not. Inhibition of glucocorticoid receptor or ADAM17 abrogated the budesonide-induced increase in CCL20 levels. We show that glucocorticoids enhance CCL20 production by bronchial epithelium, which may constitute a novel mechanism in Th17-mediated glucocorticoid-insensitive inflammation in asthma.

PMID:
24627531
DOI:
10.1183/09031936.00209513
[Indexed for MEDLINE]
Free full text
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire
    Loading ...
    Support Center